All the news

Bluepharma® in the BIO-Europe Spring® conference

18.02.2015 in Bluepharma

From March 9th to 11th, in Paris, Bluepharma aims to identify company partnerships and technologies and services commercialization/licensing opportunities.

In the pursuit of its internationalization strategy, Bluepharma takes part once again on the largest springtime life science partnering conference in Europe. This year, BIO-Europe Spring® takes place in Paris, from March 9th to 11th.

Besides Bluepharma, it is also participating on this edition Luzitin, S.A., a company from the same group, whose executive chairman will make a presentation on the 10th march, by 12h30. Sérgio Simões integrates the speakers’ panel about oncology, to update on the promising clinical results obtained in the advanced Head&Neck cancer response using the lead compound, LUZ11.

Bluepharma will be in the BIO-Europe Spring® conference looking for potential partnerships regarding its solutions on the market. The main focuses are on the fields of R&D, concerning the development of new solid oral pharmaceutical forms, namely the innovative technology of oral films BlueOS®; the industrial activity, attending to its production capacity of two billion of solid oral pharmaceutical forms; and the international commercialization of drugs.

This participation is encompassed in the scope of the Biocant International Project and funded by the incentives system to the SMEs Qualification and Internationalization.


About BIO-Europe Spring®

The event is the meeting point for start-ups and big biotech companies desiring to form business partnerships with investors and big pharma companies. In 2014, more than 2,000 attendees from 1,209 companies participated in 10,780 one-to-one meetings, involving 2,115 licensing opportunities.